| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |